Advertisement
For more than twenty years, Leksell Gamma Knife surgery has been the goldstandard in intracranial radiosurgery. With its new re-locatable frame andsupport for fractionated treatments, the Extend program now provides theability to treat large or critically located targets in the head and neck thatwere previously untreatable with Gamma Knife surgery. The result is anexciting crossover solution for neuro-oncology that combines Elekta'srecognized excellence in stereotaxy with its proven expertise in radiationmedicine.
Advertisement
"When faced with lesions that are too large or too critically located tobe safely treated in a single session, Extend enables clinicians to divide theradiation dose over multiple treatments," says Mark Symons, Senior VicePresident, Stereotactic Business Unit. "It also includes the most precisenon-invasive fixation option available, allowing both neurosurgeons andradiation oncologists to treat more patients with greater confidence."
Other Meeting Highlights
In addition to the U.S. launch of the Extend Program, Elekta also willdemonstrate its line of neurosurgery solutions capable of handling the mostdifficult cases, but flexible enough to support a comprehensive program:
-- Leksell Gamma Knife(R) Perfexion(TM) a special device finely adapted tothe task of intracranial radiosurgery.
-- Elekta Axesse(TM) a head-to-toe radiosurgery solution forneuro-oncology that effectively treats tumors while minimizing exposure tonearby healthy tissue.
-- Leksell Stereotactic System(R) the world's most widely usedstereotactic product line.
-- Elekta Neuromag(R) the world's most advanced magnetoencephalography(MEG) system.
Symons concludes: "Professor Lars Leksell envisioned a gentler alternativeto open surgery and ultimately defined the field of stereotactic radiosurgery.Today Elekta is still pushing the boundaries of science and technology toredefine excellence in stereotaxy, and thereby help to redefine the future ofhuman care."
*Extend(TM) requires 510(k) review and is not yet commercially availablein the U.S.
About Elekta
Elekta is a human care company pioneering significant innovations andclinical solutions for treating cancer and brain disorders. The companydevelops sophisticated state of the art tools and treatment planning systemsfor radiation therapy and radiosurgery, as well as workflow enhancing softwaresystems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligentand resource-efficient solutions that offer confidence to both healthcareproviders and patients, Elekta aims to improve, prolong and even save patientlives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over5,000 hospitals globally, and every day more than 100,000 patients receivediagnosis, treatment or follow-up with the help of a solution from the ElektaGroup.
Elekta employs around 2,500 employees globally. The corporate headquarteris located in Stockholm, Sweden, and the company is listed on the NordicExchange under the ticker EKTAb. For more information about Elekta, pleasevisit www.elekta.com .
SOURCE Elekta, Inc.
